Term
| inhaled corticosteroids: 5 |
|
Definition
1. Becklovent
2. Flovent
3. Pulmicort
4. Axmacort
5. Aerobid |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| singulair indicated for pts > |
|
Definition
|
|
Term
| accolate indicated for pt > |
|
Definition
|
|
Term
| zyflo indicated for pts > |
|
Definition
|
|
Term
|
Definition
|
|
Term
| short acting beta 2 agonists: |
|
Definition
1. albuterol
2. levabuterol
3. pirbuterol |
|
|
Term
| inhaled anticholinergics: |
|
Definition
|
|
Term
| systemic beta 2 agonists: |
|
Definition
| epinephrine & terbutaline |
|
|
Term
| describe pt w controlled asthma: |
|
Definition
1. <2day time sx per wk
2. no limitations of activities
3. no nocturnal sx
4. <2 uses of rescue per wk
5. normal spirometry |
|
|
Term
| describe partly controlled asthma: |
|
Definition
1. >2xwk daytime sx
2. any limitations in activities
3. any nocturnal sx
4. >2xwk rescue tx
5. <80% personal best spirometry |
|
|
Term
| describe uncontrolled asthma: |
|
Definition
| 3 or more features of partly controlled asthma in any week |
|
|
Term
|
Definition
1. rapid acting beta 2 agonist prn
2. low dose ICS
3. lox dose ICS + long acting beta2
4. med or high ICS + long acting beta2
5. lowest dose oral glucocorticosteroid |
|
|
Term
| meetered dosed inhaler indicated for pts > |
|
Definition
|
|
Term
| spcaer devices indicated in pts > |
|
Definition
|
|
Term
| novel dry powder is indicated for pts > |
|
Definition
|
|
Term
| nebulizer neessary for pts < |
|
Definition
|
|
Term
| lst % for peak flow meter categories for mild,moderate, severe, life threatening |
|
Definition
mild: >70%
moderate: 40-69%
severe: 38-26%
life threatening: <25% |
|
|
Term
| lsit severity categories for COPD based on FEV1%'s: |
|
Definition
mild: >80%
moderate: 50-80
severe: 30-50
very severe: <30 or <50 w resp failure |
|
|
Term
|
Definition
1. SAB prn
2. moderate: add LAB
3. severe: add ICS
4. very severe: add long term O2 |
|
|
Term
| indications for abx in COPD |
|
Definition
1. increased dyspnea
2. increased spu vol
3. spu purulence |
|
|
Term
| recommendations for mucolytics and antitussives in COPD |
|
Definition
|
|
Term
| only therapy to increase the survival in chronic resp failure: |
|
Definition
| long term O2 (>15hrs/day) |
|
|
